Drugs.com - FDA MedWatch Alerts

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules

Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of Prograf® 0.5mg (tacrolimus) and one lot...

Feb 9, 2025 - 21:44
 0
Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules
Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 – Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of Prograf® 0.5mg (tacrolimus) and one lot...
Read More

Tags:

Previous Article

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Informatio...

Next Article

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Soluti...

Related Posts

ICU Medical Issues Nationwide Recall of Potassium Chloride Injection, 20 mEq and Potassium Chloride Injection, 10 mEq Due to Mislabeling

ICU Medical Issues Nationwide Recall of Potassium Chlor...

Feb 16, 2025  0

Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Furosemide, Dexamethasone and Chlorpheniramine

Buy-herbal.com Issues Voluntary Nationwide Recall of Nh...

Feb 9, 2025  0

Drug Safety Communication: Ocaliva (obeticholic acid) - Serious Liver Injury Being Observed in Patients without Cirrhosis

Drug Safety Communication: Ocaliva (obeticholic acid) -...

Feb 9, 2025  0